Key Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in Biotechnology
12 févr. 2018 08h00 HE
|
Sera Prognostics, Inc.
SEATTLE and SALT LAKE CITY, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s health company, in collaboration with The Institute for Systems Biology and Integrated Diagnostics (Indi),...
Sera Prognostics to Present at the 11th Annual Canaccord Genuity Medical Technologies and Diagnostics Forum
06 nov. 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at the Baird 2017 Global Healthcare Conference
05 sept. 2017 10h49 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Sera Prognostics is Named a 2017 Silver Edison Award Winner
21 avr. 2017 07h00 HE
|
Sera Prognostics, Inc.
NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced...
Sera Prognostics to Present at 35th Annual J.P. Morgan Healthcare Conference
03 janv. 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
10 mars 2016 07h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
04 févr. 2016 15h15 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...
HGH Infrared Systems' Spynel-S Soars as part of a multi-sensor unmanned solution at the 2015 International Paris Air Show
09 juil. 2015 10h37 HE
|
HGH Infrared Systems
BOSTON, July 9, 2015 (GLOBE NEWSWIRE) -- At the 51st edition of the International Paris Air Show this year, the world's largest and oldest aerospace trade show, HGH Infrared Systems' Spynel-S was...
Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery & Sera Production Capability
06 déc. 2011 09h18 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Dec 6, 2011) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) is pleased to announce the completion of a major expansion of its...